Suchergebnisse - "Booth, Laurence"

PubPharm (107)

1

GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells

enthalten in: Oncotarget | 2024

von Booth, L. | Roberts, J. | West, C. | +1

2

GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells

enthalten in: Oncotarget | 2024

von Booth, M. | Booth, L. | Roberts, J. | +2

3

Autophagy as a therapeutic mechanism to kill drug-resistant cancer cells

enthalten in: Anti-cancer drugs | 2024

von Booth, L. | Roberts, J. | Poklepovic, A. | +1

4

Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells

enthalten in: Anti-cancer drugs | 2023

von Booth, L. | Poklepovic, A. | Hancock, J. | +1

5

A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations

enthalten in: Anti-cancer drugs | 2023

von Bordeaux, Z. | Kwatra, S. | Booth, L. | +1

6

AR12 increases BAG3 expression which is essential for Tau and APP degradation via LC3-associated phagocytosis and macroautophagy

enthalten in: Aging | 2022

von Dent, P. | Booth, L. | Roberts, J. | +4

7

Mechanisms of GZ17-6.02 resistance

enthalten in: Anti-cancer drugs | 2022

von Booth, L. | West, C. | Von Hoff, D. | +1

8

A novel plant-derived compound is synergistic with 5-fluorouracil and has increased apoptotic activity through autophagy in the treatment of actinic keratoses

enthalten in: The Journal of dermatological treatment | 2022

von West, C. | Kwatra, S. | Choi, J. | +3

9

GZ17-6.02 and axitinib interact to kill renal carcinoma cells

enthalten in: Oncotarget | 2022

von Booth, L. | West, C. | Moore, R. | +2

10

GZ17-6.02 and palbociclib interact to kill ER+ breast cancer cells

enthalten in: Oncotarget | 2022

von Booth, L. | West, C. | Moore, R. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]